Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus

BACKGROUND: The study of low-grade inflammation in patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular diseases is a pressing problem. A deeper understanding of the cascade of inflammatory reactions, possibly mediating the severe atherosclerotic lesions of various vascul...

Full description

Saved in:
Bibliographic Details
Main Authors: Vadim V. Genkel, Karina V. Nikushkina, Tansilla I. Nikonova, Igor I. Shaposhnik
Format: Article
Language:English
Published: Endocrinology Research Centre 2018-08-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/9392
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849729805039173632
author Vadim V. Genkel
Karina V. Nikushkina
Tansilla I. Nikonova
Igor I. Shaposhnik
author_facet Vadim V. Genkel
Karina V. Nikushkina
Tansilla I. Nikonova
Igor I. Shaposhnik
author_sort Vadim V. Genkel
collection DOAJ
description BACKGROUND: The study of low-grade inflammation in patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular diseases is a pressing problem. A deeper understanding of the cascade of inflammatory reactions, possibly mediating the severe atherosclerotic lesions of various vascular pools in patients with diabetes, has the potential to introduce more sophisticated diagnostic and therapeutic approaches into practice. AIM: To study the interrelation of low-grade inflammation and atherosclerosis of peripheral arteries in patients with coronary artery disease (CAD) and T2DM. MATERIALS AND METHODS: The study included 137 patients (77 men and 60 women) with CAD. The average age of patients was 62.0 (57.0–66.0) years. The first group included 67 patients with CAD and T2DM, and the second group included 70 patients with CAD. Low-grade inflammation was assessed by the levels of high-sensitivity C-reactive protein, interleukin (IL)-1β, IL-6, IL-8, IL-10 and TNF-α. All patients underwent duplex scanning of carotid arteries and lower extremity arteries (LEAs). RESULTS: Patients with CAD and T2DM showed significantly greater values of stenosis of carotid arteries and LEAs. Direct correlation was revealed between markers of inflammation and the degree of stenosis of the femoral and tibial arteries, as well as the intima-media thickness of the carotid and femoral arteries. In the group of patients with T2DM, the value of IL-1β was 2.04 (0.98–2.52) pg/mL, which was significantly less than 2.43 (1.84–3.19) pg/mL for patients in the second group (p = 0.010). The values of IL-6 were also significantly lower in the first group of patients, at 1.84 (0.73–4.41) pg/mL vs. 3.73 (2.27–10.2) pg/mL in the first and second groups, respectively (p = 0.008). The dose of metformin was inversely correlated with the level of IL-6 (r = −0.314, p = 0.003). CONCLUSIONS: Patients with CAD and T2DM compared with patients without diabetes had significantly greater values of stenosis of peripheral arteries. The levels of IL-1β and IL-6 in the group of patients with CAD and T2DM were significantly lower in comparison with patients without diabetes. The dose of metformin was inversely correlated with the level of IL-6.
format Article
id doaj-art-6238fb1e04424226b254e0d93641c02a
institution DOAJ
issn 2072-0351
2072-0378
language English
publishDate 2018-08-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj-art-6238fb1e04424226b254e0d93641c02a2025-08-20T03:09:04ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782018-08-0121317818510.14341/DM93928509Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitusVadim V. Genkel0Karina V. Nikushkina1Tansilla I. Nikonova2Igor I. Shaposhnik3<p>South-Ural State Medical University</p><p>South-Ural State Medical University</p><p>South-Ural State Medical University</p><p>South-Ural State Medical University</p>BACKGROUND: The study of low-grade inflammation in patients with type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular diseases is a pressing problem. A deeper understanding of the cascade of inflammatory reactions, possibly mediating the severe atherosclerotic lesions of various vascular pools in patients with diabetes, has the potential to introduce more sophisticated diagnostic and therapeutic approaches into practice. AIM: To study the interrelation of low-grade inflammation and atherosclerosis of peripheral arteries in patients with coronary artery disease (CAD) and T2DM. MATERIALS AND METHODS: The study included 137 patients (77 men and 60 women) with CAD. The average age of patients was 62.0 (57.0&ndash;66.0) years. The first group included 67 patients with CAD and T2DM, and the second group included 70 patients with CAD. Low-grade inflammation was assessed by the levels of high-sensitivity C-reactive protein, interleukin (IL)-1&beta;, IL-6, IL-8, IL-10 and TNF-&alpha;. All patients underwent duplex scanning of carotid arteries and lower extremity arteries (LEAs). RESULTS: Patients with CAD and T2DM showed significantly greater values of stenosis of carotid arteries and LEAs. Direct correlation was revealed between markers of inflammation and the degree of stenosis of the femoral and tibial arteries, as well as the intima-media thickness of the carotid and femoral arteries. In the group of patients with T2DM, the value of IL-1&beta; was 2.04 (0.98&ndash;2.52) pg/mL, which was significantly less than 2.43 (1.84&ndash;3.19) pg/mL for patients in the second group (p = 0.010). The values of IL-6 were also significantly lower in the first group of patients, at 1.84 (0.73&ndash;4.41) pg/mL vs. 3.73 (2.27&ndash;10.2) pg/mL in the first and second groups, respectively (p = 0.008). The dose of metformin was inversely correlated with the level of IL-6 (r = &minus;0.314, p = 0.003). CONCLUSIONS: Patients with CAD and T2DM compared with patients without diabetes had significantly greater values of stenosis of peripheral arteries. The levels of IL-1&beta; and IL-6 in the group of patients with CAD and T2DM were significantly lower in comparison with patients without diabetes. The dose of metformin was inversely correlated with the level of IL-6.https://www.dia-endojournals.ru/jour/article/view/9392peripheral artery diseasediabetes mellitusinterleukin-6interleukin-1βmetformin
spellingShingle Vadim V. Genkel
Karina V. Nikushkina
Tansilla I. Nikonova
Igor I. Shaposhnik
Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
Сахарный диабет
peripheral artery disease
diabetes mellitus
interleukin-6
interleukin-1β
metformin
title Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_full Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_fullStr Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_full_unstemmed Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_short Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
title_sort peripheral arterial disease and indicators of low grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
topic peripheral artery disease
diabetes mellitus
interleukin-6
interleukin-1β
metformin
url https://www.dia-endojournals.ru/jour/article/view/9392
work_keys_str_mv AT vadimvgenkel peripheralarterialdiseaseandindicatorsoflowgradeinflammationinpatientswithcoronaryarterydiseaseandtype2diabetesmellitus
AT karinavnikushkina peripheralarterialdiseaseandindicatorsoflowgradeinflammationinpatientswithcoronaryarterydiseaseandtype2diabetesmellitus
AT tansillainikonova peripheralarterialdiseaseandindicatorsoflowgradeinflammationinpatientswithcoronaryarterydiseaseandtype2diabetesmellitus
AT igorishaposhnik peripheralarterialdiseaseandindicatorsoflowgradeinflammationinpatientswithcoronaryarterydiseaseandtype2diabetesmellitus